Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: High stability of collagen VII favors long-term skin integrity

Molecular Therapy

Volumn 17, Issue 9, 2009, Pages 1605-1615

  Kern, Johannes S ^a,b   Loeckermann, Stefan ^a   Fritsch, Anja ^a   Hausser, Ingrid ^c   Roth, Wera ^d   Magin, Thomas M ^d   Mack, Claudia ^d   Müller, Marcel L ^a   Paul, Oliver ^b   Ruther, Patrick ^b   Bruckner Tuderman, Leena ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 7; EPIDERMAL GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL JUNCTION; CELL PROLIFERATION; CELL THERAPY; CELL VIABILITY; CONTROLLED STUDY; EPIDERMOLYSIS BULLOSA DYSTROPHICA; FIBROBLAST; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; INFLAMMATION; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN CONTENT; PROTEIN STABILITY;

ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; CELLS, CULTURED; COLLAGEN TYPE VII; EPIDERMOLYSIS BULLOSA DYSTROPHICA; FIBROBLASTS; FLOW CYTOMETRY; HUMANS; IN SITU NICK-END LABELING; MICE; MICE, TRANSGENIC; MICROSCOPY, ELECTRON, TRANSMISSION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN; TISSUE THERAPY;

MUS;

EID: 69949184884     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2009.144     Document Type: Article

References (47)

1. Fritsch, A, Loeckermann, S, Kern, JS, Braun, A, Bösl, MR, Bley, TA et al. (2008). A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy. J Clin Invest 118: 1669-1679.
2. Fine, JD, Eady, RA, Bauer, EA, Bauer, JW, Bruckner-Tuderman, L, Heagerty, A et al. (2008). The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol 58: 931-950.
3. Kern, JS and Has, C (2008). Update on diagnosis and therapy of inherited epidermolysis bullosa. Exp Rev Dermatol 3: 721-733.
4. Has, C and Bruckner-Tuderman, L (2006). Molecular and diagnostic aspects of genetic skin fragility. J Dermatol Sci 44: 129-144.
5. Aumailley, M, Has, C, Tunggal, L and Bruckner-Tuderman, L (2006). Molecular basis of inherited skin-blistering disorders, and therapeutic implications. Expert Rev Mol Med 8: 1-21.
6. Uitto, J (2008). Epidermolysis bullosa: Prospects for cell-based therapies. J Invest Dermatol 128: 2140-2142.
7. Woodley, DT, Keene, DR, Atha, T, Huang, Y, Ram, R, Kasahara, N et al. (2004). Intradermal injection of lentiviral vectors corrects regenerated human dystrophic epidermolysis bullosa skin tissue in vivo. Mol Ther 10: 318-326.
8. Ortiz-Urda, S, Thyagarajan, B, Keene, DR, Lin, Q, Fang, M, Calos, MP et al. (2002). Stable nonviral genetic correction of inherited human skin disease. Nat Med 8: 1166-1170.
9. Chen, M, Kasahara, N, Keene, DR, Chan, L, Hoeffler, WK, Finlay, D et al. (2002). Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa. Nat Genet 32: 670-675.
10. Ortiz-Urda, S, Lin, Q, Green, CL, Keene, DR, Marinkovich, MP and Khavari, PA (2003). Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue. J Clin Invest 111: 251-255.
11. Woodley, DT, Krueger, GG, Jorgensen, CM, Fairley, JA, Atha, T, Huang, Y et al. (2003). Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone. J Invest Dermatol 121: 1021-1028.
12. Goto, M, Sawamura, D, Ito, K, Abe, M, Nishie, W, Sakai, K et al. (2006). Fibroblasts show more potential as target cells than keratinocytes in COL7A1 gene therapy of dystrophic epidermolysis bullosa. J Invest Dermatol 126: 766-772.
13. Baldeschi, C, Gache, Y, Rattenholl, A, Bouillé, P, Danos, O, Ortonne, JP et al. (2003). Genetic correction of canine dystrophic epidermolysis bullosa mediated by retroviral vectors. Hum Mol Genet 12: 1897-1905.
14. Meneguzzi, G, Pin, D, Carozzo, C and Gache, Y (2008). Successful ex vivo gene therapy of recessive DEB. J Invest Dermatol 128 S124.
15. Mavilio, F, Pellegrini, G, Ferrari, S, Di Nunzio, F, Di Iorio, E, Recchia, A et al. (2006). Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nat Med 12: 1397-1402.
16. Chino, T, Tamai, K, Yamazaki, T, Otsuru, S, Kikuchi, Y, Nimura, K et al. (2008). Bone marrow cell transfer into fetal circulation can ameliorate genetic skin diseases by providing fibroblasts to the skin and inducing immune tolerance. Am J Pathol 173: 803-814.
17. Tolar, J, Ishida-Yamamoto, A, Riddle, M, McElmurry, RT, Osborn, M, Xia, L et al. (2009). Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells. Blood 113: 1167-1174.
18. Prockop, DJ and Olson, SD (2007). Clinical trials with adult stem/ progenitor cells for tissue repair: Let's not overlook some essential precautions. Blood 109: 3147-3151.
19. Fine, JD, Johnson, LB, Weiner, M, Li, KP and Suchindran, C (2009). Epidermolysis bullosa and the risk of life-threatening cancers: The National EB Registry experience, 1986-2006. J Am Acad Dermatol 60: 203-211.
20. Kern, JS, Kohlhase, J, Bruckner-Tuderman, L and Has, C (2006). Expanding the COL7A1 mutation database: Novel and recurrent mutations and unusual genotype-phenotype constellations in 41 patients with dystrophic epidermolysis bullosa. J Invest Dermatol 126: 1006-1012.
21. Heinonen, S, Männikkö, M, Klement, JF, Whitaker-Menezes, D, Murphy, GF and Uitto, J (1999). Targeted inactivation of the type VII collagen gene (Col7a1) in mice results in severe blistering phenotype: A model for recessive dystrophic epidermolysis bullosa. J Cell Sci 112: 3641-3648.
22. Wong, T, Gammon, L, Liu, L, Mellerio, JE, Dopping-Hepenstal, PJ, Pacy, J et al. (2008). Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa. J Invest Dermatol 128: 2179-2189.
23. Konig, A and Bruckner-Tuderman, L (1992). Transforming growth factor-beta stimulates collagen VII expression by cutaneous cells in vitro. J Cell Biol 117: 679-685.
24. -/- mice and in human epidermolysis bullosa simplex. Hum Mutat 30: 832-841.
25. Ruther, P, Bartholomeyczik, W, Dominicus, O, Roth, K, Seitz, W, Strauss, A et al. (2005). Novel 3D piezoresistive silicon force sensor for dimensional metrology of micro components. Proc IEEE Sensors 2005, Irvine, USA, pp. 1006-1009.
26. Hinz, B (2007). Formation and function of the myofibroblast during tissue repair. J Invest Dermatol 127: 526-537.
27. Chiquet-Ehrismann, R and Chiquet, M (2003). Tenascins: Regulation and putative functions during pathological stress. J Pathol 200: 488-499.
28. Woodley, DT, Remington, J, Huang, Y, Hou, Y, Li, W, Keene, DR et al. (2007). Intravenously injected human fibroblasts home to skin wounds, deliver type VII collagen, and promote wound healing. Mol Ther 15: 628-635.
29. Woodley, DT, Keene, DR, Atha, T, Huang, Y, Lipman, K, Li, W et al. (2004). Injection of recombinant human type VII collagen restores collagen function in dystrophic epidermolysis bullosa. Nat Med 10: 693-695.
30. Woodley, D, Wang, X, Zhou, H, Wu, T, Muirhead, T and Chen, M (2008). Bone marrow stem cells improve the survivability of RDEB mice but do not correct the fundamental type VII collagen defect. J Invest Dermatol 128: S126.
31. Fujita, Y, Abe, R, Inokuma, D, Sasaki, M, Hoshina, D, Nishie, W et al. (2008). Bone marrow transplantation restores deficient epidermal basement membrane protein and improves the clinical phenotype in epidermolysis bullosa model mice. J Invest Dermatol 128: S114.
32. Kopp, J, Horch, RE, Stachel, KD, Holter, W, Kandler, MA, Hertzberg, H et al. (2005). Hematopoietic stem cell transplantation and subsequent 80% skin exchange by grafts from the same donor in a patient with Herlitz disease. Transplantation 79: 255-256.
33. Gostynski, A, Deviaene, FC, Pasmooij, AM, Pas, HH and Jonkman, MF (2009). Adhesive stripping to remove epidermis in junctional epidermolysis bullosa for revertant cell therapy. Br J Dermatol (epub ahead of print).
34. Remington, J, Wang, X, Hou, Y, Zhou, H, Burnett, J, Muirhead, T et al. (2009). Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa. Mol Ther 17: 26-33.
35. Bruckner-Tuderman, L (2009). Can type VII collagen injections cure dystrophic epidermolysis bullosa? Mol Ther 17: 6-7.
36. Fritsch, A, Kern, JS, Loeckermann, S, Velati, D, Fassler, R and Bruckner-Tuderman, L (2009). Conditional Col7a1 inactivation allows analysis of anchoring fibril stability and function in vivo and reveals a major role of fibroblasts in collagen VII expression. J Invest Dermatol 129: S81.
37. Tidman, MJ and Eady, RA (1985). Evaluation of anchoring fibrils and other components of the dermal-epidermal junction in dystrophic epidermolysis bullosa by a quantitative ultrastructural technique. J Invest Dermatol 84: 374-377.
38. Beenken, A and Mohammadi, M (2009). The FGF family: Biology, pathophysiology and therapy. Nat Rev Drug Discov 8: 235-253.
39. Firth, SM and Baxter, RC (2002). Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23: 824-854.
40. Martin, JL and Baxter, RC (2007). Expression of insulin-like growth factor binding protein-2 by MCF-7 breast cancer cells is regulated through the phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway. Endocrinology 148: 2532-2541.
41. Martins, VL, Vyas, JJ, Chen, M, Purdie, K, Mein, CA, South, AP et al. (2009). Increased invasive behaviour in cutaneous squamous cell carcinoma with loss of basementmembrane type VII collagen. J Cell Sci 122: 1788-1799.
42. De Wever, O, Demetter, P, Mareel, M and Bracke, M (2008). Stromal myofibroblasts are drivers of invasive cancer growth. Int J Cancer 123: 2229-2238.
43. Echtermeyer, F, Streit, M, Wilcox-Adelman, S, Saoncella, S, Denhez, F, Detmar, M et al. (2001). Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4. J Clin Invest 107: R9-R14.
44. Sat, E, Leung, KH, Bruckner-Tuderman, L and Cheah, KS (2000). Tissue-specific expression and long-term deposition of human collagen VII in the skin of transgenic mice: Implications for gene therapy. Gene Ther 7: 1631-1639.
45. Zaha, V, Nitschke, R, Göbel, H, Fischer-Rasokat, U, Zechner, C and Doenst, T (2005). Discrepancy between GLUT4 translocation and glucose uptake after ischemia. Mol Cell Biochem 278: 129-137.
46. Caldelari, R, Suter, MM, Baumann, D, De Bruin, A and Müller, E (2000). Long-term culture of murine epidermal keratinocytes. J Invest Dermatol 114: 1064-1065.
47. Bruckner-Tuderman, L, Nilssen, O, Zimmermann, DR, Dours-Zimmermann, MT, Kalinke, DU, Gedde-Dahl, T et al. (1995). Immunohistochemical and mutation analyses demonstrate that procollagen VII is processed to collagen VII through removal of the NC-2 domain. J Cell Biol 131: 551-559.